Stokes Peebles, Vanderbilt University Medical Center, United States Updates Copyright 2022 Chen, Mei, Wei, Li, Qian, Min, Yang, Dong, Rao and Zhong
As a result, clinical studies show greater weight loss results
Since those trials wrapped up, a retrospective analysis of Eli Lilly's Mounjaro trials suggested that tirzepatide may have protected the kidney health of people with type 2 diabetes, whether or not they already had chronic kidney disease
Some regulators treat it as a complex generic, especially if chemically synthesised, while others lean toward biosimilar frameworks
Apr 28 2010;4:35-41